The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $1.04 in the prior trading day, Biodexa Pharmaceuticals Plc ADR (NASDAQ: BDRX) closed at $0.80, down -23.43%. In other words, the price has decreased by -$23.43 from its previous closing price. On the day, 1.37 million shares were traded.
Ratios:
Our goal is to gain a better understanding of BDRX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.75 and its Current Ratio is at 1.75. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Ladenburg Thalmann on February 08, 2024, initiated with a Buy rating and assigned the stock a target price of $8.
Stock Price History:
Over the past 52 weeks, BDRX has reached a high of $41.50, while it has fallen to a 52-week low of $1.01. The 50-Day Moving Average of the stock is -39.52%, while the 200-Day Moving Average is calculated to be -80.69%.
